 Renal Insufficiency, Chronic
"Renal Insufficiency, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Descriptor ID |
D051436
|
| MeSH Number(s) |
C12.777.419.780.750 C13.351.968.419.780.750
|
| Concept/Terms |
Renal Insufficiency, Chronic- Renal Insufficiency, Chronic
- Chronic Renal Insufficiencies
- Renal Insufficiencies, Chronic
- Chronic Renal Insufficiency
- Chronic Kidney Insufficiency
- Kidney Insufficiency, Chronic
- Chronic Kidney Insufficiencies
- Kidney Insufficiencies, Chronic
|
Below are MeSH descriptors whose meaning is more general than "Renal Insufficiency, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Renal Insufficiency, Chronic".
This graph shows the total number of publications written about "Renal Insufficiency, Chronic" by people in this website by year, and whether "Renal Insufficiency, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 | | 2008 | 3 | 0 | 3 | | 2009 | 3 | 1 | 4 | | 2010 | 7 | 2 | 9 | | 2011 | 6 | 0 | 6 | | 2012 | 8 | 4 | 12 | | 2013 | 21 | 3 | 24 | | 2014 | 19 | 5 | 24 | | 2015 | 21 | 3 | 24 | | 2016 | 13 | 1 | 14 | | 2017 | 19 | 6 | 25 | | 2018 | 15 | 3 | 18 | | 2019 | 21 | 1 | 22 | | 2020 | 23 | 4 | 27 | | 2021 | 25 | 3 | 28 | | 2022 | 22 | 1 | 23 |
To return to the timeline, click here.
Below are the most recent publications written about "Renal Insufficiency, Chronic" by people in Profiles.
-
Akwo E, Pike MM, Ertuglu LA, Vartanian N, Farber-Eger E, Lipworth L, Perwad F, Siew E, Hung A, Bansal N, de Boer I, Kestenbaum B, Cox NJ, Ikizler TA, Wells Q, Robinson-Cohen C. Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure: A Mendelian Randomization Study. Clin J Am Soc Nephrol. 2022 08; 17(8):1183-1193.
-
Rivera E, Levoy K, Clark-Cutaia MN, Schrauben S, Townsend RR, Rahman M, Lash J, Saunders M, Frazier R, Rincon-Choles H, Hirschman KB. Content Validity Assessment of the Revised Illness Perception Questionnaire in CKD Using Qualitative Methods. Int J Environ Res Public Health. 2022 07 16; 19(14).
-
Uribarri J, Goldfarb DS, Raphael KL, Rein JL, Asplin JR. Beyond the Urine Anion Gap: In Support of the Direct Measurement of Urinary Ammonium. Am J Kidney Dis. 2022 Nov; 80(5):667-676.
-
Bruinius JW, Hannan M, Chen J, Brown J, Kansal M, Meza N, Saunders MR, He J, Ricardo AC, Lash JP. Self-reported Physical Activity and Cardiovascular Events in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2022 Dec; 80(6):751-761.e1.
-
Lerma EV, Wilson DJ. Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes. Expert Rev Clin Pharmacol. 2022 May; 15(5):501-513.
-
Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Ruilope LM, Boletis J, Toto R, Umpierrez GE, Wanner C, Wada T, Scott C, Joseph A, Ogbaa I, Roberts L, Scheerer MF, Bakris GL. Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrol Dial Transplant. 2022 06 23; 37(7):1261-1269.
-
Torres J, Ennis JL, Chapman AB, McGill RL. Utilization of Cystatin C in the Outpatient Setting. Am J Nephrol. 2022; 53(7):534-541.
-
Singh AK, Cizman B, Carroll K, McMurray JJV, Perkovic V, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Wiecek A, Stankus N, Strutz F, Blackorby A, Cobitz AR, Meadowcroft AM, Paul G, Ranganathan P, Sedani S, Solomon S. Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial. JAMA Intern Med. 2022 06 01; 182(6):592-602.
-
Young TK, Toussaint ND, Di Tanna GL, Arnott C, Hockham C, Kang A, Schutte AE, Perkovic V, Mahaffey KW, Agarwal R, Bakris GL, Charytan DM, Heerspink HJL, Levin A, Pollock C, Wheeler DC, Zhang H, Jardine MJ. Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial. J Diabetes Res. 2022; 2022:9998891.
-
Agarwal R, Anker SD, Bakris G, Filippatos G, Pitt B, Rossing P, Ruilope L, Gebel M, Kolkhof P, Nowack C, Joseph A. Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone. Nephrol Dial Transplant. 2022 05 25; 37(6):1014-1023.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|